Grant: Applied Research and Development Grants - Level 1
La Cité collégiale
$29,999.00
Development of an Innovative Point-of-Care Screening Tool for Alzheimer's Disease
FY 2021-22
Summary
Recherches Neuro-Hippocampe Inc. is a private clinical research institution comprised of physicians and researchers studying Alzheimer's disease for the past 20 years. They are currently conducting Phase 2b and Phase 3 clinical trials at their Ottawa and Gatineau sites. It has been shown that early detection of Alzheimer's disease allows for improved efficacy of therapeutic interventions and quality of life. Therefore, as part of their preclinical program, and in collaboration with two research centers at La Cité, RNH aims to develop a point-of-care diagnostic tool to non-invasively detect risk genes associated with Alzheimer's disease in the younger at-risk population. The Centre for Expertise in Smart Prototyping, and the Technology Access Centre of Bio-Innovation, at La Cité have the expertise in personnel and specialized equipment to help RNH in their endeavor.
Program
Applied Research and Development Grants - Level 1
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
569580-2021
Name nom
Méthot, Nathalie
Department département
Head Office
Organization id
28248
Institution établissement
La Cité collégiale
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
29999
Program id
CARD1
Program name en
Applied Research and Development Grants - Level 1
Program name fr
Subventions de recherche et développement appliquée - niveau 1
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1561
Committee name en
Applied Research and Development Grants
Committee name fr
Subventions de recherche et développement appliquée
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Installment
inst:1
Partie
1
Nb partie
1
Application title
Development of an Innovative Point-of-Care Screening Tool for Alzheimer's Disease
Keyword
NSERC
Application summary
Recherches Neuro-Hippocampe Inc. is a private clinical research institution comprised of physicians and researchers studying Alzheimer's disease for the past 20 years. They are currently conducting Phase 2b and Phase 3 clinical trials at their Ottawa and Gatineau sites. It has been shown that early detection of Alzheimer's disease allows for improved efficacy of therapeutic interventions and quality of life. Therefore, as part of their preclinical program, and in collaboration with two research centers at La Cité, RNH aims to develop a point-of-care diagnostic tool to non-invasively detect risk genes associated with Alzheimer's disease in the younger at-risk population. The Centre for Expertise in Smart Prototyping, and the Technology Access Centre of Bio-Innovation, at La Cité have the expertise in personnel and specialized equipment to help RNH in their endeavor.
